Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales

References 

1. Burris S, Vernick JS, Ditzler A, Strathdee S. The legality of selling or giving syringes to injection drug users. Journal of the American Pharmacists Association (Washington). 2002;42(6 Suppl. 2):S13–S18
2. Burris S, Strathdee SA, Vernick JS. Lethal injections: The law, science, and politics of syringe access for injection drug users. The University of San Francisco Law Review. 2003;37(4):813–885
3. Carlson RG, Wang J, Siegal HA. An ethnographic approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Human Organization. 1994;53:279–286
4. CDC . Syringe exchange programs—United States, 2005. MMWR Morbidity and Mortality Weekly Report. 2007;56(44):1164–1167
5. Compton WM, Cottler LB, Decker SH, Mager D, Stringfellow R. Legal needle buying in St. Louis. American Journal of Public Health. 1992;82(4):595–596
   • MEDLINE
   • CrossRef
6. Compton WM, Horton JC, Cottler LB, Booth R, Leukefeld CG, Singer M, et al. A multistate trial of pharmacy syringe purchase. Journal of Urban Health. 2004;81(4):661–670
7. Darke S. Self-report among injecting drug users: A review. Drug and Alcohol Dependence. 1998;51(3):253–263[discussion 267–258]
   • Abstract
   • Full Text
   • Full-Text PDF (95 KB)
   • CrossRef
8. Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: Relations to population density, HIV prevalence, and HIV incidence. American Journal of Public Health. 2001;91(5):791–793
   • MEDLINE
   • CrossRef
9. Friedman SR, Cooper HL, Tempalski B, Keem M, Friedman R, Flom PL, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS. 2006;20(1):93–99
   • MEDLINE
10. Fuller CM, Galea S, Blaney S, Ompad DC, Deren S, Des Jarlais D, et al. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity and Disease. 2004;14(4):589–596
11. Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. American Journal of Public Health. 2007;97(1):117–124
    • CrossRef
12. Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Education and Prevention. 2002;14(5):367–378
13. McNeely J, Arnsten JH, Gourevitch MN. Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: A cross-sectional survey. Harm Reduction Journal. 2006;3:8
14. Needle R, Fisher DG, Weatherbee N, Chitwood D, Brown B, Cesari H, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors. 1995;9:242–250
15. North Carolina Administrative Code. (2007). Title 21, Occupational Licensing Boards and Commissions: Pharmacy. Section 1800-Prescriptions, 21 NCAC 46.1801, Right to refuse a prescription. Available at http://ncrules.state.nc.us/ncac/title%2021%20-20occupational%20licensing%20boards%20and%20commissions/chapter%2046%20-%20pharmacy/21%20ncac%2046%20.1801.pdf. Accessed on 10 February, 2009.
16. North Carolina General Statutes. (1994). G.S. § 90-113.22. Manufacture or delivery of drug paraphernalia. Available at http://www.ncleg.net/enactedlegislation/statutes/pdf/bysection/chapter_90/gs_90-113.23.pdf. Accessed on 10 February, 2009.
17. Reich W, Compton WM, Horton JC, Cottler LB, Cunningham-Williams RM, Booth R, et al. Pharmacist ambivalence about sale of syringes to injection drug users. Journal of the American Pharmacists Association (Washington). 2002;42(6 Suppl. 2):S52–S57
18. Simpson HL. Injection drug users and pharmacists: A call for compassion, cooperation, and care. Journal of the American Pharmacists Association (Washington). 2002;42(6 Suppl. 2):S10–S12
19. Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: Follow-up findings from Hartford, Connecticut. Public Health Report. 1998;113(June (Suppl. 1)):81–89
20. Stimson GV. AIDS and injecting drug use in the United Kingdom, 1987–1993: The policy response and the prevention of the epidemic. Social Science and Medicine. 1995;41(5):699–716
21. Taussig JA, Weinstein B, Burris S, Jones TS. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. Aids. 2000;14(Suppl. 1):S47–S51
    • CrossRef
22. The Legal of Prescribing and Dispensing Sterile Injection Equipment to IDUs to Prevent Disease Transmission. Available at http://www.temple.edu/lawschool/aidspolicy/apolicy.htm Accessed on 5 December, 2009.
23. van Ameijden EJ, Coutinho RA. Large decline in injecting drug use in Amsterdam, 1986–1998: Explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health. 2001;55(5):356–363
24. Wasley A, Miller JT, Finelli L. Surveillance for acute viral hepatitis—United States, 2005. MMWR Surveillance Summaries. 2007;56(3):1–24
25. Watters JK, Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Problems. 1989;36:416–430
26. Weatherby NL, Needle R, Cesari H, Booth R, McCoy CB, Watters JK, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning. 1994;17(4):347–355
    • CrossRef
27. Wodak A. Lessons from the first international review of the evidence for needle syringe programs: The band still plays on. Substance Use and Misuse. 2006;41(6–7):837–839
28. Zule WA, Costenbader EC, Meyer WJ, Wechsberg WM. Methamphetamine use and risky sexual behaviors during heterosexual encounters. Sexually Transmitted Diseases. 2007;34(9):689–694
    • CrossRef
29. Zule WA, Costenbader EC, Coomes CM, Wechsberg WM. Effects of an HCV risk reduction motivational intervention on alcohol use, injection and sexual risk behaviors. American Journal of Public Health. 2009;99(S1):S180–S186
    • CrossRef